Objective: Midaortic syndrome (MAS) is defined as a diffuse or segmental narrowing of the descending thoracic or abdominal aorta.
Those patients are frequently associated with renal or visceral artery steno-occlusive lesion. Congenital or acquired etiology has been reported for MAS. In children with MAS, idiopathic or congenital hypoplasia is most frequent, whereas Takayasu arteritis is a common etiology in adult patients. The purpose of this study was to review clinical features and treatment results of idiopathic MAS (IMAS).
Methods: IMAS is defined as MAS that is not consistent with diagnostic criteria of Takayasu arteritis. We searched all patients with MAS from a database at a single institution, which was collected during the past 23 years. Among MAS patients, patients with aortic lesion due to Takayasu arteritis or atherosclerosis were excluded from this study. Patients who underwent aortic intervention (either endovascular or open surgical treatment) were included for this study. For treatment of aortic stenosis, 12 open surgical bypasses (10 anatomic aortic bypasses and 1 ascending aorta to descending thoracic aorta bypass; 1 axillofemoral bypass) and 5 endovascular treatments (2 aortic stent, 2 aortic balloon angioplasty, and 1 aortic stent graft) were performed. Six renal arteries and one superior mesenteric artery bypass were performed concomitantly with aortic bypass.
Results: Table I and II demonstrate patient and lesion characteristics. Median age was 25 years at the time of presentation, and it was more prevalent in women (65%). Hypertension and leg claudication were the most common clinical symptoms. Stroke, heart failure, and coronary artery disease developed at a younger age in this group of patients. Aortic stenosis was most common in the proximal infrarenal aortic segment, and renal or visceral branch involvement was noted in one-third of patients. After open surgical treatment, there was no surgical mortality, but it was followed by postoperative morbidity in 18%. During the follow-up period (median, 76.6 months; interquartile range, 13-119.6 months), aortic restenosis developed in 8% after open surgical treatment vs in 60% after endovascular treatment.
Conclusions: For patients with IMAS, open surgical treatment is recommended for long-term efficacy of treatment.
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